Mural Oncology (NASDAQ:MURA) stock plummets 47% as the company, a spinoff of Alkermes (ALKS) halts a Phase 3 trial for its ...

Thrivent Financial for Lutherans reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 3.3% in the fourth ...

On St. Patrick's Day, everybody's a little Irish. Alkermes, Aon, Jazz Pharmaceuticals, PDD Holdings and CRH are five ...

Alkermes plc (NASDAQ:ALKS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen research firms that are covering the stock, MarketBeat.com reports. Four investment ...

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report), with ...

in Williams v. Alkermes, Inc.: Defendant Alkermes, Inc. is a large pharmaceutical company with a principal place of business in Waltham, Massachusetts. Plaintiff Travis Williams worked as ...

In this article, we are going to take a look at where Alkermes plc (NASDAQ ... Long-Term Investment Opportunities Speaking ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS ...

Alkermes belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Vertex Pharmaceuticals (VRTX), has gained 8.7% over the past month. More than a ...